AADR vs BBC

Both AADR and BBC are ETFs. AADR has a lower 5-year return than BBC (3.36% vs 4.7%). AADR has a higher expense ratio than BBC (1.1% vs 0.79%). Below is the comparison between AADR and BBC.

AADR BBC
Segment Equity: Global Ex-U.S. - Total Market Growth Equity: U.S. Biotech
Issuer AdvisorShares Virtus
Net Assets $69.25M $37.32M
Expense Ratio 1.10% 0.79%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.68% 0.00%
Underlying Index -- LifeSci Biotechnology Clinical Trials Index
YTD Return -13.66% 8.03%
1-Year Return 3.18% 48.07%
3-Year Return -1.15% 23.10%
5-Year Return 3.36% 4.70%
10-Year Return N/A N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return -13.66%
1-Month Return 6.91%
3-Month Return -17.61%
1-Year Return 3.18%
3-Year Return -1.15%
5-Year Return 3.36%
10-Year Return N/A
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (41.23% of Total Assets)

Name Symbol % Assets
Galapagos NV ADR GLPG 6.19%
NICE Ltd ADR NICE 5.42%
argenx SE ADR ARGX 4.32%
ZTO Express (Cayman) Inc ADR ZTO 4.04%
TAL Education Group ADR TAL 3.83%
MercadoLibre Inc MELI.SA 3.82%
Anglogold Ashanti Ltd ADR AU.JO 3.45%
ASML Holding NV ADR ASML 3.42%
AstraZeneca PLC ADR AZN.L 3.38%
Gold Fields Ltd ADR GFI.JO 3.36%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

BBC description

The Fund seeks investment results that correspond to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering clinical trial stage of development.

BBC performance & returns

YTD Return 8.03%
1-Month Return 28.93%
3-Month Return 8.44%
1-Year Return 48.07%
3-Year Return 23.10%
5-Year Return 4.70%
10-Year Return N/A
BBC expense ratio is 0.79%.

BBC holdings

Top 10 Holdings (18.32% of Total Assets)

Name Symbol % Assets
Forty Seven Inc FTSV 3.43%
Moderna Inc MRNA 2.07%
CEL-SCI Corp CVM 1.92%
ChemoCentryx Inc CCXI 1.64%
Axsome Therapeutics Inc AXSM 1.62%
Intra-Cellular Therapies Inc ITCI 1.54%
Alector Inc ALEC 1.53%
Principia Biopharma Inc PRNB 1.53%
Akebia Therapeutics Inc AKBA 1.52%
Fate Therapeutics Inc FATE 1.52%

Other relevant BBC comparisons

You may also want to check out the following BBC comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
    Follow Us